$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2019 Q1 Form 10-Q Financial Statement

#000156459019017199 Filed on May 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1 2017 Q3
Revenue $48.15M $650.1K $8.714M
YoY Change 7306.0% -92.77% 27784.11%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.340M $3.680M $9.530M
YoY Change 45.11% -47.05% -27.36%
% of Gross Profit
Research & Development $20.80M $12.00M $8.280M
YoY Change 73.3% 4.93% -29.05%
% of Gross Profit
Depreciation & Amortization $750.9K $1.200M $1.200M
YoY Change -37.43% 0.0% 33.33%
% of Gross Profit
Operating Expenses $26.14M $15.68M $18.96M
YoY Change 66.66% 3.76% -4.15%
Operating Profit $22.01M -$15.03M -$10.25M
YoY Change -246.41% 145.27% -52.97%
Interest Expense $1.890M $168.3K -$480.0K
YoY Change 1022.69% 54.81% 0.0%
% of Operating Profit 8.59%
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income $23.90M -$14.88M -$10.73M
YoY Change -260.62% 146.36% -51.71%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $23.90M -$14.88M -$10.73M
YoY Change -260.55% 146.32% -51.71%
Net Earnings / Revenue 49.63% -2289.45% -123.16%
Basic Earnings Per Share $0.25 -$0.18
Diluted Earnings Per Share $0.24 -$0.18 -$143.5K
COMMON SHARES
Basic Shares Outstanding 94.16M 84.08M
Diluted Shares Outstanding 98.08M 84.08M

Balance Sheet

Concept 2019 Q1 2018 Q1 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $218.2M $91.50M $65.60M
YoY Change 138.47% 5.66% -23.19%
Cash & Equivalents $161.6M $69.80M $24.84M
Short-Term Investments $56.60M $21.70M $40.80M
Other Short-Term Assets $3.400M $1.100M $1.360M
YoY Change 209.09% -54.17% -63.95%
Inventory
Prepaid Expenses $867.4K
Receivables $13.40M $0.00 $67.80K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $235.0M $92.70M $67.90M
YoY Change 153.51% 3.34% -24.97%
LONG-TERM ASSETS
Property, Plant & Equipment $13.40M $14.60M $15.51M
YoY Change -8.22% -7.01% 0.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $67.50M
YoY Change
Other Assets $100.0K $100.0K $141.9K
YoY Change 0.0% -50.0% 16.01%
Total Long-Term Assets $98.90M $34.30M $36.12M
YoY Change 188.34% -7.8% -4.19%
TOTAL ASSETS
Total Short-Term Assets $235.0M $92.70M $67.90M
Total Long-Term Assets $98.90M $34.30M $36.12M
Total Assets $333.9M $127.0M $104.0M
YoY Change 162.91% 0.08% -18.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.100M $1.800M $4.077M
YoY Change 127.78% -30.77% -66.59%
Accrued Expenses $6.700M $5.000M $4.565M
YoY Change 34.0% 66.67% -46.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $200.0K
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $101.8M $9.100M $18.70M
YoY Change 1018.68% -67.03% -27.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $2.200M $2.300M
YoY Change -100.0% -8.33% -8.0%
Other Long-Term Liabilities $31.50M $1.900M $2.100M
YoY Change 1557.89% -47.22% 950.0%
Total Long-Term Liabilities $31.50M $4.100M $4.400M
YoY Change 668.29% -31.67% -41.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $101.8M $9.100M $18.70M
Total Long-Term Liabilities $31.50M $4.100M $4.400M
Total Liabilities $132.7M $12.70M $22.60M
YoY Change 944.88% -61.52% -31.83%
SHAREHOLDERS EQUITY
Retained Earnings -$432.8M
YoY Change 8.63%
Common Stock $652.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $201.2M $114.3M $81.42M
YoY Change
Total Liabilities & Shareholders Equity $333.9M $127.0M $104.0M
YoY Change 162.91% 0.08% -18.84%

Cashflow Statement

Concept 2019 Q1 2018 Q1 2017 Q3
OPERATING ACTIVITIES
Net Income $23.90M -$14.88M -$10.73M
YoY Change -260.55% 146.32% -51.71%
Depreciation, Depletion And Amortization $750.9K $1.200M $1.200M
YoY Change -37.43% 0.0% 33.33%
Cash From Operating Activities -$19.60M -$15.40M -$9.200M
YoY Change 27.27% 7.69% -9.8%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K -$400.0K -$100.0K
YoY Change -50.0% -71.43% -96.43%
Acquisitions
YoY Change
Other Investing Activities -$11.00M $17.20M -$4.100M
YoY Change -163.95% -169.35% -510.0%
Cash From Investing Activities -$11.20M $16.80M -$4.200M
YoY Change -166.67% -164.12% 133.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.700M 56.90M -100.0K
YoY Change -95.25% 28350.0% -100.19%
NET CHANGE
Cash From Operating Activities -19.60M -15.40M -9.200M
Cash From Investing Activities -11.20M 16.80M -4.200M
Cash From Financing Activities 2.700M 56.90M -100.0K
Net Change In Cash -28.10M 58.30M -13.50M
YoY Change -148.2% -244.67% -132.45%
FREE CASH FLOW
Cash From Operating Activities -$19.60M -$15.40M -$9.200M
Capital Expenditures -$200.0K -$400.0K -$100.0K
Free Cash Flow -$19.40M -$15.00M -$9.100M
YoY Change 29.33% 16.28% 22.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2670037
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-50342
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
652411876
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
582902694
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
82806171
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4159946
CY2019Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2018Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
arwr:TechnologyLicensesCollaborativeResearchAndDevelopmentArrangementsResearchGrantsAndProductSalesMember
CY2018Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
12002354
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3681830
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
15684184
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-15034059
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
432141
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
23896982
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-14884311
us-gaap Net Income Loss
NetIncomeLoss
35934235
us-gaap Net Income Loss
NetIncomeLoss
-28083189
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94155407
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84083937
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92623615
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79406838
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98082644
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84083937
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97214546
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79406838
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-28162
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1561
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7967
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23868820
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14882750
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
35883893
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28091156
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
70199310
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1456813
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
193125
CY2018Q1 arwr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
218217
CY2018Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-54668
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2601348
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24838567
us-gaap Interest Paid Net
InterestPaidNet
27437
us-gaap Interest Paid Net
InterestPaidNet
88537
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23740787
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9805362
us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
us-gaap Depreciation
Depreciation
1444425
CY2019Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
124096728
CY2019Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
755661
arwr Increase Decrease In Cash And Investments
IncreaseDecreaseInCashAndInvestments
209200000
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2019Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3927237
CY2018Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
600334
CY2018Q3 arwr Research Equipment Gross
ResearchEquipmentGross
10751627
CY2018Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
152676
CY2018Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
12236150
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
8570708
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
14528257
CY2019Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2019Q1 us-gaap Purchase Obligation
PurchaseObligation
52100000
CY2019Q1 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
27100000
CY2019Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
25000000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5524399
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
712500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
47557
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
702242
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5487100
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4052157
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.14
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.26
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1277188
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1308973
CY2019Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
162798
CY2019Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
124689591
CY2018Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
46400176
CY2018Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
429050
CY2018Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
45971126
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
425107
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
850214
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700429
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700429
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700429
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700429
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
10261865
CY2019Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
150000000
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
436000
CY2018Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
305000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
771000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
630000
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
932495
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1192771
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1246122
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
7.01
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.23
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.17
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.26
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
61552640
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
49183457
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.023
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.021
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.031
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.027
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.10
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
At vesting, each outstanding RSU will be exchanged for one share of the Company’s Common Stock. RSU recipients may elect to net share settle upon vesting, in which case the Company pays the employee’s income taxes due upon vesting and withholds a number of shares of Common Stock of equal value. RSU awards generally vest subject to the satisfaction of service requirements or the satisfaction of both service requirements and achievement of certain performance targets.
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0

Files In Submission

Name View Source Status
0001564590-19-017199-index-headers.html Edgar Link pending
0001564590-19-017199-index.html Edgar Link pending
0001564590-19-017199.txt Edgar Link pending
0001564590-19-017199-xbrl.zip Edgar Link pending
arwr-10q_20190331.htm Edgar Link pending
arwr-20190331.xml Edgar Link completed
arwr-20190331.xsd Edgar Link pending
arwr-20190331_cal.xml Edgar Link unprocessable
arwr-20190331_def.xml Edgar Link unprocessable
arwr-20190331_lab.xml Edgar Link unprocessable
arwr-20190331_pre.xml Edgar Link unprocessable
arwr-ex311_10.htm Edgar Link pending
arwr-ex312_9.htm Edgar Link pending
arwr-ex321_6.htm Edgar Link pending
arwr-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending